Kleiner Device Labs

Kleiner Device Labs

Early Stage

Patented devices that allow spine surgery to be less painful, less expensive, and provide better outcomes

Patented devices that allow spine surgery to be less painful, less expensive, and provide better outcomes

Overview

Raised to Date: Raised: $1,069,999

Total Commitments ($USD)

Platform

Equifund

Start Date

05/16/2021

Close Date

04/20/2022

Min. Goal
$24,997
Max. Goal
$1,069,999
Min. Investment

$438

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$3.50

Pre-Money Valuation

$28,500,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$3,166

# of Investors

681

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2013

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

High

Location

Incline Village, Nevada

Business Type

Growth

Kleiner Device Labs, with a valuation of $28.5 million, is raising crowdfunding on Equifund CFP. The company is developing and patenting a revolutionary way of doing spinal surgeries with its KG1 bone graft delivery tool. The KG tool of Kleiner Device Labs increases the successful spinal fusion rate to 92% compared to 75% through other techniques. Dr. Jeffrey Kleiner founded Kleiner Device Labs in 2013. The proceeds of the current crowdfunding round, with a minimum raise of $24,997 and a maximum raise of $1,069,999, will be used for the launch of new products and marketing. Kleiner Device Labs’ KG device transforms the complex spinal surgery process into a simple one-step process. It also decreases blood loss, reduces the chances of infection, and shortens anesthesia time.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$43,333

$29,812

COGS

$8,454

$6,348

Tax

$0

$0

 

 

Net Income

$-1,570,970

$-784,549

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$140,141

$173,413

Accounts Receivable

$6,920

$9,531

Total Assets

$585,816

$282,262

Short-Term Debt

$694,592

$863,509

Long-Term Debt

$6,724

$12,666

Total Liabilities

$701,316

$876,175

Financials as of: 05/16/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Kleiner Device Labs on Equifund CFP
Platform: Equifund
Security Type: Equity - Common
Valuation: $28,500,000
Price per Share: $3.50

Follow company

Follow Kleiner Device Labs on Equifund CFP

Buy Kleiner Device Labs's Deal Report

Warning: according to the close date for this deal, Kleiner Device Labs may no longer be accepting investments.

Kleiner Device Labs Deal Report

Get KingsCrowd’s comprehensive report on Kleiner Device Labs including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Kleiner Device Labs is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Kleiner Device Labs deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge